Plain-English translation of NCT07621003 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a newer heart procedure called pulsed field ablation to treat atrial fibrillation (an irregular heartbeat). Half of participants will receive this new procedure within 21 days, while the other half will take anti-arrhythmic medications to manage their condition. The research team believes this newer technique may work better and cause fewer side effects than current treatment options.
Atrial fibrillation can lead to serious health complications, and early treatment has been shown to help. This trial is investigating whether the new treatment technique can improve outcomes better than traditional medication-based approaches, and whether it may be safer by causing less damage to surrounding heart structures.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll be randomly assigned to either the new procedure group or the medication group. If assigned to the procedure group, you'll receive the pulsed field ablation heart procedure within 21 days. If assigned to the medication group, you'll start or continue taking anti-arrhythmic medications as recommended by your doctor. The study will follow your heart rhythm and symptoms to compare how well each approach works.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
Germany